In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Innovations in CMR for coronary artery disease
Session

Event : ESC Congress 2019

Topic : Cardiac Magnetic Resonance

  • Session type : Moderated Posters
  • Date : 02 September 2019
  • Time : 12:05 - 12:55

7 presentations in this session

Feasibility and prognostic value of vasodilator stress perfusion CMR in elderly patients > 75 years without known CAD

Event : ESC Congress 2019

  • Session : Innovations in CMR for coronary artery disease
  • Speaker : T Pezel (Paris,FR)

Left ventricular thrombus formation after ST-elevation myocardial infarction: a prospective observational CMR study

Event : ESC Congress 2019

  • Session : Innovations in CMR for coronary artery disease
  • Speaker : M Holzknecht (Innsbruck,AT)

Atrioventricular mechanical coupling and major adverse cardiac events in female patients following acute ST elevation myocardial infarction

Event : ESC Congress 2019

  • Session : Innovations in CMR for coronary artery disease
  • Speaker : SJ Backhaus (Goettingen,DE)

Anti-thrombin nanoparticles limit ischemia-reperfusion injury and no-reflow in myocardial infarction

Event : ESC Congress 2019

  • Session : Innovations in CMR for coronary artery disease
  • Speaker : H Pan (Tampa,US)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are